Introduction {#sec1}
============

Obesity is a chronic disease resulting from interactions of multiple genetic, metabolic, environmental, and behavioral factors and leading to increased morbidity and mortality rates \[[@cit0001], [@cit0002]\]. A meta-analysis of 15 prospective studies carried out in a total of 258,000 patients was published in the *European Heart Journal* to show that abdominal obesity as measured by waist circumference and waist-to-hip ratio (WHR) is associated with increased risk of cardiovascular diseases. A 1-cm increase in waist circumference increases the cardiovascular risk by 2% while a 0.01 increase in waist--hip ratio (WHR) increases this risk by as much as 5% \[[@cit0003], [@cit0004]\]. Despite numerous studies, the assessment of cardiovascular risk in the group of patients with morbid obesity undergoing different methods of bariatric surgery requires further verification \[[@cit0005]--[@cit0007]\].

Aim {#sec2}
===

Researchers unambiguously state that increased fat indices (EAT, EMT, PATIMA) are correlated with increased cardiovascular risk \[[@cit0006], [@cit0008]--[@cit0010]\]. Thus, we designed a study to examine the novel non-invasive predictors of coronary disease, namely the carotid extra-media thickness (EMT), PATIMA, and epicardial adipose tissue (EAT), as well as their correlation with the conventional cardiovascular risk factors, in a group of patients with morbid obesity undergoing preparation for bariatric surgery. In addition, the study group was compared to an age- and gender-matched control group consisting of subjects with normal body weight.

Material and methods {#sec3}
====================

Study group {#sec3.1}
-----------

The study group consisted of 40 female patients with morbid obesity (body mass index (BMI) \> 40 kg/m^2^), average age of 36.4 ±9.0 years; median 37 years (19.0--53.0) not suffering from type 2 diabetes, hospitalized for qualification for elective bariatric surgery. We did not include patients with a history of myocardial infarction, patients with significant valvular defects, chronic renal diseases, chronic obstructive pulmonary disease, active smokers, or patients with severe obstructive sleep apnea (AHI ≥ 30). The control group consisted of 15 non-obese females at the mean age of 36 ±8.34 years, with average body weight of 60.72 ±5.12 kg. Patients in the control group were selected so as to match the age and gender distribution in the study group.

Anthropometric examinations and laboratory investigations {#sec3.2}
---------------------------------------------------------

All patients were subjected to body weight, BMI, body fat weigh and lean body mass measurements using a TBF-300 Tanita Body Composition Analyzer. The device automatically analyzes body composition with the accuracy of ±0.1 kg on the basis of differences in electric bioimpedance, i.e. the differences in electric conductivity between aqueous and adipose compartments. In addition, the body surface area (BSA) was determined using the Mosteller equation: (height^0.5^ × body weight^0.5^)/60, and excess body weight (EBW) was calculated using the current body weight minus ideal body weight formula. The ideal body weight was calculated as height in cm -- 100 -- 10%.

Laboratory investigations were carried out including fasting glucose, 75-g oral glucose tolerance test, fasting insulin, glycated hemoglobin (HbA~1c~), lipid profile, glomerular filtration rate (GFR), creatinine, serum glucose (mg/dl) and insulin levels (μIU/ml) as measured by immunochromatography. Normal insulin level was defined as 5--15 μIU/ml. In addition, the HOMA insulin resistance and quantitative insulin sensitivity check indices (QUICKI) were calculated using the formulas HOMA-IR = insulin (μIU/ml) × glucose (mmol/l)/22.5 and QUICKI = 1/(log(insulin (μIU/ml)) + log(glucose (mmol/l))).

Ultrasound scans {#sec3.3}
----------------

The following measurements were made: EMT is the distance between the carotid media-adventitia border and the jugular lumen interface. The measurements were made manually due to the lack of dedicated software. The average of 3 measurements was used for calculations. We used a standardized EMT protocol, including measurements along a 7-mm segment starting 3 mm proximally to the carotid bulb. All examinations were performed and evaluated by a single experienced physician. Examinations were performed using a Philips iE 33 system (Andover, Massachusetts USA) with a 5--7 MHz linear array transducer.

The EAT measurements were carried out on the free right ventricular wall as visualized in two projections, the long axis and short axis parasternal view; the average of 3 measurements was used for calculations. This is a standardized measurement method correlated with the gold standard of MRI measurements. All examinations were performed and evaluated by a single physician. Examinations were carried out using a Philips iE 33 system (Andover, Massachusetts USA) with a 2.5--3.5 MHz transducer.

The periarterial adipose tissue intima media adventitia (PATIMA) index was calculated using the formula PATIMA = (EMT/BMI × 35) + IMT + EAT × 60. EMT and EAT measurements were carried out as described above. The IMT, i.e. the thickness of the carotid artery tunica intima and tunica media, was measured in fasting subjects as an average of 3 measurements of the posterior walls of the left and right common carotid arteries 2 cm from the bulb. All examinations were performed and evaluated by a single physician. Examinations were carried out using a Philips iE 33 system (Andover, Massachusetts USA) with a 5--7 MHz linear array transducer.

The study was approved by the appropriate bioethics committee.

Statistical analysis {#sec3.4}
--------------------

Descriptive statistics are reported as medians with range and means with standard deviations. Due to the relatively small size of the control group, the Mann-Whitney test was used in all comparisons of continuous variables. Relationships between continuous variables in the patient group were estimated using Spearman's rho coefficient. The level of statistical significance was established at *p* \< 0.05. Calculations were performed using the SAS 9.2 software.

Results {#sec4}
=======

Clinical characteristics {#sec4.1}
------------------------

Arterial hypertension (H) was defined on the basis of arterial blood pressure measurements (systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg) or of the anti-hypertensive treatment received at the time of the study. On the basis of these criteria, H was diagnosed in 95% of patients, including 30 patients treated with at least two anti-hypertensive agents (including angiotensin-converting enzyme inhibitors and diuretics) and 8 patients treated with angiotensin-converting enzyme inhibitors alone.

Prediabetic condition was diagnosed on the basis of impaired fasting glycemia (IFG) or impaired glucose tolerance (IGT). IFG was detected in 6 (15%) patients while IGT was detected in 7 (17.5%) patients; in 2 patients both disorders were observed simultaneously. In 19 (48.71%) patients fasting insulin levels were found to exceed 15 μIU/ml, indicating hyperinsulinemia. In 26 (67%) patients, HOMA-IR exceeded the normal limit of 2.5. Lipid metabolism disorders were diagnosed in 22 (55%) patients while 8 (20%) patients suffered from mild to moderate obstructive sleep apnea. All patients were assessed for the possible occurrence of metabolic syndrome. All patients met the NCEP-ATP III diagnostic criteria of metabolic syndrome as defined in 2001 and subsequent updates. Also, all patients met the diagnostic criteria as defined by the IDF in 2005.

Basic characteristics of patients are presented in [Table I](#t0001){ref-type="table"}. Fat tissue parameters are presented in [Table II](#t0002){ref-type="table"}.

###### 

Basic characteristics of patients with morbid obesity

  Parameter                     Mean     SD
  ----------------------------- -------- -------
  Body weight \[kg\]            132.03   18.42
  BMI \[kg/m^2^\]               47.73    6.18
  FAT \[%\]                     49.15    3.83
  FFM \[kg\]                    66.78    7.84
  BSA M \[m^2^\]                2.47     0.20
  EBW \[kg\]                    72.34    16.75
  Fasting glucose \[mg/dl\]     90.4     10.19
  Fasting insulin \[μIU/ml\]    17.68    11.29
  2 h glucose \[mg/dl\]         109.58   31.16
  2 h insulin \[μIU/ml\]        60.72    53.93
  QUICKI                        0.94     0.19
  HOMA-IR                       3.89     2.33
  Creatinine \[mg/dl\]          0.76     0.16
  Total cholesterol \[mg/dl\]   199.15   35.13
  HDL-chol \[mg/dl\]            52.55    10.97
  LDL-chol \[mg/dl\]            120.3    31.59
  Triglycerides \[mg/dl\]       124.78   47.7
  hsCRP \[mg/l\]                10.19    6.92
  HbA~1c~ (%)                   5.8      0.89
  GFR \[ml/min\]                96.16    20.76

###### 

Fat tissue parameters in patients with morbid obesity

  Parameter    Min.      Med.      Mean      Max.      SD
  ------------ --------- --------- --------- --------- --------
  EAT_LAX      3.50      5.29      5.27      7.63      0.83
  EAT_SAX      3.70      5.11      5.37      7.46      1.01
  EAT_MEAN     3.60      5.09      5.32      7.34      0.89
  PATIMA       1212.53   1497.32   1507.90   1771.50   124.78
  PATIMA_LAX   1221.53   1495.57   1504.78   1788.90   123.81
  EMT_MEAN     721.00    808.50    804.73    888.00    39.67
  EAT_BMI      0.07      0.11      0.11      0.16      0.02
  EMT_BMI      12.26     17.06     17.10     20.97     2.13

The comparison of fat tissue parameters between patients with morbid obesity and patients in the control group is presented in [Table III](#t0003){ref-type="table"}.

###### 

Comparison of fat tissue parameters between patients with morbid obesity (OB) and patients in the control group (CG)

  Parameter    GK min.   GK median   GK max.   OB min.   OB median   OB max.   *P*-value
  ------------ --------- ----------- --------- --------- ----------- --------- -----------
  EAT LAX      3.20      3.56        3.88      3.50      5.29        7.63      \< 0.0001
  EAT SAX      3.10      3.42        3.90      3.70      5.11        7.46      \< 0.0001
  EATmean      3.31      3.50        3.72      3.60      5.09        7.34      \< 0.0001
  PATIMA       1723.69   1835.48     1970.81   1212.53   1497.32     1771.50   \< 0.0001
  PATIMA LAX   1722.49   1844.53     1977.11   1221.53   1495.57     1788.90   \< 0.0001
  EMTmean      703.00    737.00      788.00    721.00    808.50      888.00    \< 0.0001
  EAT BMI      0.14      0.16        0.18      0.07      0.11        0.16      \< 0.0001
  EMT BMI      31.75     33.96       38.89     12.26     17.06       20.97     \< 0.0001
  BMI          18.90     21.90       23.80     40.10     46.73       64.25     \< 0.0001
  FAT %        18.30     24.50       36.30     39.60     49.65       56.10     \< 0.0001
  FM           9.20      14.80       23.30     47.17     63.43       96.94     \< 0.0001
  FFM          39.70     45.80       50.70     53.80     67.27       83.38     \< 0.0001

EATmean differs significantly between groups (OB vs. CG): 5.09 vs. 3.50, *p* \< 0.0001. Moreover, EMTmean differs significantly between groups (OB vs. CG): 808.50 vs. 737.00, *p* \< 0.0001.

Correlations between selected parameters within the study group are presented in [Table IV](#t0004){ref-type="table"}.

###### 

Correlations between selected parameters within the study group. Spearman's rho correlation coefficients are presented below the diagonal line while statistical significance is presented above the diagonal line

  R            EAT LAX   EAT SAX    EAT MEAN   PATIMA   PATIMA LAX   EMT MEAN   EAT BMI    EMT BMI    BMI        FAT      FM         FFM
  ------------ --------- ---------- ---------- -------- ------------ ---------- ---------- ---------- ---------- -------- ---------- ----------
  EAT LAX                \< 0.001   \< 0.001   0.001    0.002        \< 0.001   \< 0.001   0.550      0.152      0.938    0.601      0.485
  EAT SAX      0.86                 \< 0.001   0.001    0.006        \< 0.001   \< 0.001   0.376      0.327      0.620    0.941      0.418
  EAT MEAN     0.96      0.97                  0.001    0.003        \< 0.001   \< 0.001   0.425      0.218      0.781    0.819      0.446
  PATIMA       0.55      0.52       0.55                \< 0.001     0.004      \< 0.001   0.100      0.593      0.280    0.687      0.702
  PATIMA LAX   0.55      0.45       0.51       0.99                  0.007      0.001      0.116      0.591      0.346    0.693      0.784
  EMT MEAN     0.79      0.77       0.81       0.49     0.46                    \< 0.001   0.060      0.582      0.554    0.962      0.465
  EAT BMI      0.71      0.77       0.77       0.60     0.56         0.66                  \< 0.001   0.019      0.016    0.011      0.157
  EMTBMI       0.09      0.14       0.12       0.34     0.32         0.29       0.71                  \< 0.001   0.001    \< 0.001   \< 0.001
  BMI          0.20      0.17       0.19       --0.18   --0.18       0.11       --0.46     --0.91                0.001    \< 0.001   \< 0.001
  FAT          --0.06    --0.06     --0.06     --0.25   --0.25       --0.10     --0.40     --0.55     0.54                \< 0.001   0.964
  FM           0.04      0.06       0.05       --0.14   --0.15       0.01       --0.47     --0.77     0.82       0.78                \< 0.001
  FFM          0.13      0.16       0.15       0.10     0.09         0.13       --0.24     --0.53     0.59       --0.06   0.57       

Discussion {#sec5}
==========

Our study facilitated noninvasive evaluation of early atherosclerotic markers in patients with morbid obesity as compared to a control group; several important findings were made. When comparing both the age- and gender-matched groups, note should be taken of the statistically significant differences in adipose tissue indices. This is important since EMT, EAT, and PATIMA were documented to be correlated with the incidence and stage of coronary heart disease \[[@cit0009], [@cit0011]\]. This was the first study conducted in a group of patients with morbid obesity and indicative of the presence of correlations between the novel adipose tissue markers and the risk of cardiovascular diseases.

Based on the study by Haberka *et al.*, the mean EMT values in the group of patients with morbid obesity warrant the assumption that the coronary heart disease encompasses 1 coronary vessel in ≥ 50% of patients. In this group of patients, the sensitivity and specificity values for EMT are 60% and 76%, respectively. The pioneering character of the study requires that these results be validated in a larger group of patients, perhaps in reference to calcium scores as obtained in coronary CT scans or to the coronary CT scans in patients in whom the risk was determined to be the highest. Of note, the results of our study should be validated in a larger group of patients and in patients with coronary heart disease confirmed in an invasive manner.

Moreover, epicardial adipose tissue (EAT) was shown to present with characteristics similar to those of the abdominal adipose tissue. It may cause local inflammation and thus promote coronary atherosclerosis \[[@cit0012]\]. Moreover, it is now evident that EAT-secreted bioactive molecules may play an important role in the pathogenesis of coronary artery disease and cardiac arrhythmia \[[@cit0013]--[@cit0015]\]. Of note, lower EAT density and increased EAT volume were associated with coronary calcification, serum levels of plaque inflammatory markers and MACE. That is why it could be a good tool for screening patients undergoing bariatric surgery, facilitating diagnosis of patients who need further treatment \[[@cit0016], [@cit0017]\]. Moreover, in a meta-analysis increasing EAT was associated with the presence of high-risk plaque. However, also this meta-analysis underlines that further evaluation is needed \[[@cit0018]\].

Clinical implications {#sec5.1}
---------------------

Yerramasu *et al.* showed that patients with increased EAT are at higher risk of quick atherosclerotic plaque growth. In the Framingham study, adipose tissue measurements were correlated with higher incidence of myocardial infarction. After elimination of limitations such as the population size and gender bias, our study may contribute to these adipose tissue parameters being used in cardiovascular risk screening examinations \[[@cit0019], [@cit0020]\]. Secondly, the number of patients included in our group was relatively small. Moreover, the lack of a long follow-up may be considered as a limitation, so further long-term studies are needed.

Conclusions {#sec6}
===========

Strong correlations were identified between EAT PATIMA, and EMT MEAN. The above-mentioned fat indices were not found to correlate significantly with BMI or other body weight-related parameters used to assess the adipose tissue content. Further studies are required to determine whether these markers may be used for cardiovascular risk screening in this group of patients.
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